These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1333470)

  • 1. The Lambert-Eaton syndrome.
    Smith RG; Appel SH
    Hosp Pract (Off Ed); 1992 Dec; 27(12):101-6, 111-3, 116. PubMed ID: 1333470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
    Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
    Giovannini F; Sher E; Webster R; Boot J; Lang B
    Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Fukumoto S; Motomura M
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():793-800. PubMed ID: 26480796
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
    Peers C; Johnston I; Lang B; Wray D
    Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
    Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
    Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert Eaton myasthenic syndrome.
    Petty R
    Pract Neurol; 2007 Aug; 7(4):265-7. PubMed ID: 17636143
    [No Abstract]   [Full Text] [Related]  

  • 13. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
    Blandino JK; Kim YI
    Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome.
    Katz JS; Wolfe GI; Bryan WW; Tintner R; Barohn RJ
    Neurology; 1998 Feb; 50(2):470-5. PubMed ID: 9484374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
    Motomura M; Johnston I; Lang B; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):85-7. PubMed ID: 7823075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lambert-Eaton myasthenic syndrome].
    Sakai K
    Ryoikibetsu Shokogun Shirizu; 2000; (31):56-8. PubMed ID: 11269163
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
    Goldstein JM; Waxman SG; Vollmer TL; Lang B; Johnston I; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1138-9. PubMed ID: 8089692
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome.
    Sauter M; Bender A; Heller F; Sitter T
    Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.